Pivotal Therapeutics Inc.
PVTTF
OTC PK
| 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | |
|---|---|---|---|---|---|
| Net Income | 45.92% | 40.67% | 34.24% | 103.57% | -216.07% |
| Total Depreciation and Amortization | 7.94% | 16.06% | 36.71% | 18.56% | 117.24% |
| Total Amortization of Deferred Charges | -- | 680.04% | 172.57% | 1,531.25% | -- |
| Total Other Non-Cash Items | -84.15% | -51.64% | -75.73% | -819.97% | -- |
| Change in Net Operating Assets | 363.76% | 839.81% | 90.69% | 77.55% | -251.30% |
| Cash from Operations | 101.17% | 95.83% | 67.34% | 47.78% | -238.26% |
| Capital Expenditure | 100.00% | 100.00% | 96.18% | 29.60% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 61.17% | 47.42% | -210.16% | 56.26% | -- |
| Cash from Investing | 90.10% | 79.45% | 83.21% | 53.93% | -- |
| Total Debt Issued | -- | -- | -- | -75.71% | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -107.60% | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 100.81% | 95.01% | -107.60% | -297.19% | -4,181.91% |